Clinical AI

More Than Half of US Physicians Now Deploy AI in Clinical Settings as Adoption Accelerates 34% in Under a Year

Doximity's 2026 survey of 3,151 physicians reveals 54% now use AI in practice, with daily users reporting up to five hours weekly in reclaimed administrative time and nearly half gaining capacity for new patients.

2 min read
HA
Health AI Central Editorial Team
Editorial standards & disclosures
July 16, 2026
2 min read
Share:
More Than Half of US Physicians Now Deploy AI in Clinical Settings as Adoption Accelerates 34% in Under a Year

Artificial intelligence has crossed the adoption threshold in American medicine, with more than half of US physicians now integrating AI tools into their clinical workflows, according to Doximity's 2026 State of AI in Medicine Report. The survey of 3,151 physicians documents a dramatic acceleration from 47% adoption in early 2025 to 63% by early 2026, signaling that AI has moved from experimental technology to mainstream clinical infrastructure in less than a year.

The findings suggest a tipping point in healthcare technology adoption, with 94% of physicians either currently using AI or expressing interest in doing so. Among adopters, usage intensity is high: 69% deploy AI tools daily or more frequently, with 37% of all survey respondents using AI at least once daily. This pattern indicates that once physicians integrate AI into practice, it rapidly becomes essential rather than optional.

Administrative Relief Drives Adoption

The primary catalyst for adoption appears to be relief from documentation burden. Literature search functionality led use cases at 35%, representing a 59% increase from 22% in the previous survey period. Voice and ambient documentation tools captured 29% of use cases, up from 20% previously. These administrative applications dominate over diagnostic or treatment-planning uses, reflecting physician priorities around workflow efficiency.

The payoff is measurable: 75% of AI users report reduced administrative burden and improved job satisfaction, while 49% say they now have greater capacity for new patients. Physicians estimate reclaiming one to five hours weekly from administrative tasks, with 40% redirecting that time toward direct patient care. These capacity gains translate to potential revenue increases for practices and improved access for patients, though the self-reported nature of these metrics warrants validation through objective time-motion studies.

Specialty Variations and Demographic Patterns

Adoption rates vary significantly by specialty, with neurology leading at 64%, followed by gastroenterology at 61% and internal medicine at 60%. These cognitive specialties, characterized by complex diagnostic reasoning and heavy documentation requirements, appear most receptive to AI augmentation.

The data also reveals a gender gap, with 57% of male physicians adopting AI compared to 49% of female physicians—a disparity that may reflect differences in practice settings, specialty distribution, or technology access. Notably, only 6% of physicians express no interest in AI, suggesting market saturation potential approaching 95%.

Clinical Impact and Implementation Considerations

Sixty-nine percent of users report better patient care and outcomes, though the absence of objective clinical metrics or patient-reported outcome measures means these claims require rigorous validation. The enthusiasm may reflect reduced cognitive load and burnout rather than measurable quality improvements, though both outcomes carry clinical value.

For healthcare organizations evaluating AI investments, the 16-percentage-point adoption surge over eight months provides a benchmark for implementation timelines. The high daily usage rate among adopters suggests that successful deployment requires comprehensive training and workflow redesign rather than simple technology provisioning. Organizations lagging the 54% baseline risk competitive disadvantage in physician recruitment and patient capacity.

The trajectory from 47% to 63% adoption in under a year positions 2026 as the inflection point when AI transitioned from innovation to standard of care in American medicine, with implications for medical education, liability frameworks, and reimbursement models that have yet to catch up with clinical reality.


Source: Doximity 2026 Report via quasa.io

Companies in this article

Reporting & accountability

How we maintain accuracy

Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.

Share: